HQD: The Leading E-Cigarette Brand in Russia

Business by 2FIRSTS.ai
Jun.20.2023
HQD: The Leading E-Cigarette Brand in Russia
2FIRSTS reports on HQD's success as a leading e-cigarette brand in Russia, despite recent industry struggles and new regulations.

On June 17th and 18th, the Vape Club Show Moscow e-cigarette exhibition took place at the Crocus Expo Convention Center in Moscow. As the official media partner of the event, 2FIRSTS provided on-site coverage of the exhibition.

 

At the exhibition, 2FIRSTS interviewed a representative of HQD, a Russian distributor for the e-cigarette brand. He shared with 2FIRSTS the reasons why HQD is leading the e-cigarette market in Russia and his outlook for the future.

 

In 2019, the e-cigarette industry faced a downturn with people doubting its future prospects. Sales decreased and the path to market recovery seemed uncertain. However, during this critical time, HQD saw the potential in a new disposable device based on nicotine salt, becoming one of the first brands to promote this category of product in Russia.

 

The distributors of HQD have consistently received support from professional retailers by offering the best commercial terms, high-quality service, and superior product quality in the market. As a result, all e-cigarettes in Russia are now colloquially referred to as "Ashka" or "Ashkudishka" (both of which are phonetic translations of HQD in Russian), similar to how all printers are called "Xerox.

 

He summarized the three key factors that contributed to HQD's success in the Russian market.

 

First and foremost, collaborate with reliable partners. Secondly, provide high-quality product standards. Lastly, formulate strategic and effective marketing plans after careful consideration.

 

He holds an open attitude towards a series of e-cigarette control bills recently introduced in Russia.

 

He believes that when it comes to restrictions on certain ingredients in e-liquid, communication and negotiation should be held with industry representatives and associations. Only by fully understanding the market situation can positive decisions be made that benefit the market changes. These bills and upcoming lists of substance ingredients will have a significant regulatory impact on the market, so it is important to involve as many stakeholders as possible in the decision-making process.

 

He himself holds an optimistic view on the development of the e-cigarette market in Russia. He believes that within the next 10 years, up to 30% of traditional cigarette smokers will switch to smoke-free products, thus greatly reducing the mortality rate caused by traditional tobacco consumption.

 

Furthermore, extensive research, including studies conducted by medical experts, has demonstrated the benefits of many other vaporized products such as e-cigarettes, particularly in terms of their lower health risks. Therefore, whether decision-makers have taken these factors into sufficient consideration will have a significant impact on the development of the market.

 


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Italy Fines PMI €7 Million Over Misleading ‘Smoke-Free Future’ Marketing Claims
Italy Fines PMI €7 Million Over Misleading ‘Smoke-Free Future’ Marketing Claims
Italy’s Competition and Market Authority (AGCM) has fined Philip Morris Italia €7 million, finding that the company’s use of “smoke-free future” and related claims in promoting products such as IQOS, VEEV and ZYN could mislead consumers.
Jun.16
Trump’s Tobacco Investments and Industry Donations Draw Scrutiny as FDA Eases Vape and Nicotine Pouch Rules
Trump’s Tobacco Investments and Industry Donations Draw Scrutiny as FDA Eases Vape and Nicotine Pouch Rules
A report by KFF Health News says that as the Trump administration pursued a series of policies favorable to the nicotine and tobacco industry, President Donald Trump increased his holdings in tobacco companies while benefiting from substantial industry-linked political donations, prompting questions from public health advocates about potential conflicts of interest and regulatory direction.
Jun.12
 NYT: Reynolds American Donated $5 Million Before FDA Vape Policy Shift
NYT: Reynolds American Donated $5 Million Before FDA Vape Policy Shift
According to The New York Times, Reynolds American donated $5 million to a Trump-backed super PAC shortly before the FDA introduced a new policy that could benefit major tobacco companies seeking to sell flavored vaping products.
News
May.21
State Registries Are Reshaping U.S. Vape Market Access 2Firsts Interview with U.S. Vapor Manufacturers Association President Allison Boughner
State Registries Are Reshaping U.S. Vape Market Access 2Firsts Interview with U.S. Vapor Manufacturers Association President Allison Boughner
As the U.S. vapor market faces FDA authorizations, import seizures and growing state-level restrictions, AVM President Allison Boughner told 2Firsts that state product registries and white-list systems are having the most immediate impact. She said distributors are placing greater weight on documentation, product origin and supply-chain transparency.
Special Report
May.26
Altria and Juul Ask Court to Pause Antitrust Case Pending Ninth Circuit Review
Altria and Juul Ask Court to Pause Antitrust Case Pending Ninth Circuit Review
Altria and Juul are asking a California federal court to pause an antitrust case while they appeal a class certification ruling to the Ninth Circuit. The case alleges that Altria’s 2018 investment in Juul, a $12.8 billion deal for a 35% stake.
May.07 by 2FIRSTS.ai
 Zyn Emerges as MAGA Cultural Symbol Amid FDA Policy Shift
Zyn Emerges as MAGA Cultural Symbol Amid FDA Policy Shift
According to The Wall Street Journal, nicotine pouch brand Zyn has rapidly gained popularity across the Trump administration and conservative political circles, including among U.S. Health Secretary Robert F. Kennedy Jr.
Business
May.20